Dow Jones and S&P 500 pulled ahead Tuesday morning after AI names plunged Monday. Nvidia stock tried to rebound on the stock ...

Cathie Wood kept buying uranium refiner Cameco on Monday even as the DeepSeek reaction hammered nuclear-related stocks.

Learn more about the presidencies of stakes created in Cedar City and Highland, Utah; Kasapa, Democratic Republic of the ...

Highlights,AbbVie lowers its FY2025 earnings estimate to $12.02 per share.,Shares of AbbVie see fluctuating performance, with ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other biopharma firms. Aside from JPM conference coverage, our reporters are making their way around town for one-on ...

Jan 13 (Reuters) - AbbVie (ABBV.N), opens new tab has obtained the option to license a new blood cancer drug candidate from Simcere Pharmaceutical's (2096.HK), opens new tab unit for markets ...

Nvidia warns of 'significant demand' for the graphics cards, which go on sale early Thursday morning. Still, Nvidia says it'll be shipping more supplies to retailers every day. With an early MSI ...

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...